Skip to main content
. 2021 Nov 11;11:766822. doi: 10.3389/fonc.2021.766822

Table 1.

Characteristics of the patients with limited-stage small cell lung cancer included in this study.

Age (years), median [range] 60.8 [30.8–77.6]
Sex, no. (%)
 Male 22 (88.0)
 Female 3 (12.0)
Smoker, no. (%)
 Current/former ≥20 pack-years 17 (68.0)
 Current/former <20 pack-years 1 (4.0)
 No 7 (28.0)
Location of lesion, no. (%)
 Right upper lobe 7 (28.0)
 Right middle lobe 2 (8.0)
 Right lower lobe 6 (24.0)
 Left upper lobe 6 (24.0)
 Left lower lobe 4 (16.0)
AJCC stage, no. (%)
 II 4 (16.0)
 III 21 (84.0)
Karnofsky performance status at diagnosis, median [range] 90 [80–100]
Induction chemotherapy
 No. (%) 25 (100.0)
 No. of cycles, median [range] 2 [1–5]
Concurrent chemotherapy
 No. (%) 25 (100.0)
 No. of cycles, median [range] 1 [1–2]

AJCC, American Joint Committee on Cancer.